Novo Integrated Sciences Stock Market Value

NVOS Stock  USD 0  0.00  0.00%   
Novo Integrated's market value is the price at which a share of Novo Integrated trades on a public exchange. It measures the collective expectations of Novo Integrated Sciences investors about its performance. Novo Integrated is selling for under 0.0027 as of the 4th of January 2026; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.0027.
With this module, you can estimate the performance of a buy and hold strategy of Novo Integrated Sciences and determine expected loss or profit from investing in Novo Integrated over a given investment horizon. Check out Novo Integrated Correlation, Novo Integrated Volatility and Novo Integrated Alpha and Beta module to complement your research on Novo Integrated.
Symbol

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Integrated. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Integrated listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Novo Integrated Sciences is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Integrated's value that differs from its market value or its book value, called intrinsic value, which is Novo Integrated's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Integrated's market value can be influenced by many factors that don't directly affect Novo Integrated's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Integrated's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Integrated is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Integrated's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Novo Integrated 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novo Integrated's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novo Integrated.
0.00
12/05/2025
No Change 0.00  0.0 
In 31 days
01/04/2026
0.00
If you would invest  0.00  in Novo Integrated on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding Novo Integrated Sciences or generate 0.0% return on investment in Novo Integrated over 30 days. Novo Integrated is related to or competes with Sonendo. Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related p... More

Novo Integrated Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novo Integrated's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novo Integrated Sciences upside and downside potential and time the market with a certain degree of confidence.

Novo Integrated Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Novo Integrated's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novo Integrated's standard deviation. In reality, there are many statistical measures that can use Novo Integrated historical prices to predict the future Novo Integrated's volatility.
Hype
Prediction
LowEstimatedHigh
0.00050.14
Details
Intrinsic
Valuation
LowRealHigh
0.00050.14
Details
Naive
Forecast
LowNextHigh
0.00010.01185.39
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.000100
Details

Novo Integrated Sciences Backtested Returns

Novo Integrated is out of control given 3 months investment horizon. Novo Integrated Sciences has Sharpe Ratio of 0.24, which conveys that the firm had a 0.24 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-five different technical indicators, which can help you to evaluate if expected returns of 45.34% are justified by taking the suggested risk. Use Novo Integrated Sciences Downside Deviation of 55.0, mean deviation of 88.79, and Risk Adjusted Performance of 0.1834 to evaluate company specific risk that cannot be diversified away. Novo Integrated holds a performance score of 19 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 32.77, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Novo Integrated will likely underperform. Use Novo Integrated Sciences sortino ratio, semi variance, as well as the relationship between the Semi Variance and day typical price , to analyze future returns on Novo Integrated Sciences.

Auto-correlation

    
  -0.27  

Weak reverse predictability

Novo Integrated Sciences has weak reverse predictability. Overlapping area represents the amount of predictability between Novo Integrated time series from 5th of December 2025 to 20th of December 2025 and 20th of December 2025 to 4th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novo Integrated Sciences price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current Novo Integrated price fluctuation can be explain by its past prices.
Correlation Coefficient-0.27
Spearman Rank Test0.47
Residual Average0.0
Price Variance0.0

Novo Integrated Sciences lagged returns against current returns

Autocorrelation, which is Novo Integrated stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Novo Integrated's stock expected returns. We can calculate the autocorrelation of Novo Integrated returns to help us make a trade decision. For example, suppose you find that Novo Integrated has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Novo Integrated regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Novo Integrated stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Novo Integrated stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Novo Integrated stock over time.
   Current vs Lagged Prices   
       Timeline  

Novo Integrated Lagged Returns

When evaluating Novo Integrated's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Novo Integrated stock have on its future price. Novo Integrated autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Novo Integrated autocorrelation shows the relationship between Novo Integrated stock current value and its past values and can show if there is a momentum factor associated with investing in Novo Integrated Sciences.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Novo Stock Analysis

When running Novo Integrated's price analysis, check to measure Novo Integrated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Integrated is operating at the current time. Most of Novo Integrated's value examination focuses on studying past and present price action to predict the probability of Novo Integrated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Integrated's price. Additionally, you may evaluate how the addition of Novo Integrated to your portfolios can decrease your overall portfolio volatility.